AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. INO
  4. [SCHEDULE 13G/A] Inovio Pharmaceuticals, Inc. SEC Filing

[SCHEDULE 13G/A] Inovio Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock INO logo
Inovio Pharmaceu

NASDAQ:INO

INO Rankings

#7317 Ranked by Market Cap
N/A Ranked by Dividends

INO Latest News

Aug 4, 2025
INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025
Jul 7, 2025
INOVIO to Present at Upcoming Scientific Conference
Jul 3, 2025
INOVIO Announces Pricing of $25 Million Public Offering
Jul 2, 2025
INOVIO Announces Proposed Public Offering
May 13, 2025
INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

INO Latest SEC Filings

Jul 7, 2025
[8-K] Inovio Pharmaceuticals, Inc. Reports Material Event
Jul 3, 2025
[424B5] Inovio Pharmaceuticals, Inc. Prospectus Supplement (Debt Securities)
Jul 2, 2025
[424B5] Inovio Pharmaceuticals, Inc. Prospectus Supplement (Debt Securities)
Jul 1, 2025
[Form 4] Inovio Pharmaceuticals, Inc. Insider Trading Activity

INO Stock Data

72.87M
50.67M
0.53%
27.13%
11.75%
Biotechnology
Pharmaceutical Preparations
United States
PLYMOUTH MEETING